Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01
Go back to Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01| (NASDAQ: EVAX) | Delayed: 3.39 -0.03 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.42 | 52 Week High | $ | |||
| Open | $3.40 | 52 Week Low | $ | |||
| Day High | $3.60 | P/E | N/A | |||
| Day Low | $3.38 | EPS | $ | |||
| Volume | 11,474 | |||||
